Indoco Remedies Ltd has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its sterile and solid dosages facility (Goa Plant II) situated at L-32/33/34 Verna Industrial Estate, Goa. This approval confirms the closure of inspection conducted in July'2015.

The stock closed l4% higher at Rs.299.

The scrip opened at Rs. 265.85 and has touched a high and low of Rs. 309 and Rs. 265.85 respectively. So far 716885(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 2424.93 crore.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 413.1 on 25-May-2015 and a 52 week low of Rs. 244 on 25-Feb-2016. Last one week high and low of the scrip stood at Rs. 272 and Rs. 258.25 respectively.

The promoters holding in the company stood at 59.25 % while Institutions and Non-Institutions held 20.78 % and 19.98 % respectively.

The stock is currently trading above its 200 DMA.